CARMINE C MARCHIOLI
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology DU BOIS, PA NPI 1861592016
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology PA Daiichi Sankyo Inc. All categories
General Payments — all program years on this page
$8,930.61
- Category: General Payments
- Program years: PY2018–2024
- Record count: 606
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $984.42 across 54 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $984.42 | 54 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $158.72 | 6 |
| PFIZER INC. | $123.38 | 8 |
| Incyte Corporation | $105.39 | 5 |
| ABBVIE INC. | $67.66 | 4 |
| EISAI INC. | $51.50 | 3 |
| Rigel Pharmaceuticals, Inc. | $47.51 | 4 |
| E.R. Squibb & Sons, L.L.C. | $46.07 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $46.01 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.87 | 2 |
| Janssen Biotech, Inc. | $34.49 | 2 |
| Merck Sharp & Dohme Corporation | $33.40 | 2 |
| GlaxoSmithKline, LLC. | $32.89 | 2 |
| Acerta Pharma LLC | $23.80 | 1 |
| Genentech USA, Inc. | $20.41 | 1 |
| Pharmacosmos Therapeutics Inc. | $20.21 | 1 |
| TerSera Therapeutics LLC | $19.73 | 1 |
| TOLMAR, INC. | $18.91 | 1 |
| GENZYME CORPORATION | $18.82 | 1 |
| Alexion Pharmaceuticals, Inc. | $18.24 | 1 |
| Sumitomo Pharma America, Inc. | $16.96 | 1 |
| Regeneron Healthcare Solutions, Inc. | $16.89 | 1 |
| ARRAY BIOPHARMA INC | $15.00 | 1 |
| ADC Therapeutics America, Inc. | $13.56 | 1 |
By program year
Records — PY2024 (54)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.